Updated
2026 Pioneering Medical Device Award Winner: QuantalX Neuroscience
Engineering breakthroughs that save lives.
“QuantalX Neuroscience earned this recognition for introducing a first-of-its-kind approach to functional brain assessment in clinical care. Delphi-MD™ stood out not only for its technical sophistication, but for the way it helps move neurological evaluation beyond indirect observation and toward objective, repeatable measurement of brain network function. That combination of innovation, regulatory progress, and clinical relevance made QuantalX a clear standout.” Jordan Hayes HealthTechNode Awards Coordinator
Pioneering Medical Device Award
Redefining Care Through Cutting-Edge Medical Technology.
Winner: QuantalX Neuroscience
QuantalX Neuroscience is helping redefine how brain health can be assessed in routine clinical settings. Its Delphi-MD™ platform is designed to directly measure brain network function through a non-invasive combination of transcranial magnetic stimulation, electroencephalography, and advanced algorithmic analysis. Rather than relying only on structural imaging, cognitive testing, or subjective clinical interpretation, the system gives clinicians objective, quantitative insight into how the brain is functioning in real time.
What made Delphi-MD™ especially compelling was its role in introducing a new category of clinically accessible neurofunctional assessment. The platform stimulates targeted brain networks, records electrophysiological response signatures, and compares those results against an age-correlated normative database to generate standardized, repeatable reports. That approach helps support earlier detection of abnormalities, longitudinal monitoring of functional change, and more informed decision-making across neurological care.
The entry also demonstrated meaningful momentum and credibility. QuantalX highlighted major milestones including FDA De Novo classification, Breakthrough Device Designation, U.S. commercialization, and a dedicated CPT reimbursement code supporting integration into clinical workflows. Together, those achievements helped show that Delphi-MD™ is not only a bold technical innovation, but a device platform with real potential to make advanced functional brain assessment more practical and scalable in everyday care.
- Introduces a direct, non-invasive method for assessing brain network function in clinical settings
- Combines TMS, EEG, and advanced analytics into a standardized, repeatable device workflow
- Achieved FDA De Novo classification and Breakthrough Device Designation
- Supports routine clinical use through a dedicated CPT reimbursement code
- Represents a meaningful step from structural observation toward functional brain measurement
About the Award
The Pioneering Medical Device Award recognizes breakthrough devices and hardware-enabled innovations that push healthcare forward through new capabilities, improved precision, and stronger clinical utility. This category honors technologies that help expand what is possible in diagnosis, monitoring, intervention, or patient care through meaningful advances in device design and performance.
Explore more winners. Visit the main winners archive for other HealthTechNode award recipients, or explore the broader awards program.
View all winners Explore all awards
Questions? Contact awards@healthtechnode.com